Brief: Wilex Q1 net loss widens to 2.0 million euros

Heidelberg Pharma AG

12/04/2017 06:20

April 12 (Reuters) - Wilex AG  WL6G.DE : 
    * Outlook for 2017: increase in sales revenue forecast; 
investments in proprietary atac pipeline 
    * Financial guidance remains unchanged compared to that 
provided on 30 March 2017 
    * In first three months of fiscal year 2017, Wilex Group 
generated sales revenue and income totaling 0.6 million euros 
(previous year: 1.0 million euros) 
    * Net loss for first three months of fiscal year increased 
to 2.0 million euros, as planned (previous year: 1.1 million 
euros) 
    * Based on current planning and assuming planned corporate 
actions are carried out, company's financing is secured until 
end of Q2 of 2018 
 
Source text for Eikon:  ID:nEQ1yhSFx  
Further company coverage:  WL6G.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))